COGT
Cogent Biosciences Inc
31.40$
+0.1%
vs. previous close
Closing price · As of: Sep 24, 2026
Statements
Balance Sheet
All figures as a percentage of total assets in the same period.
Tick rows to compare them in a chart (up to 4)
| Line item | Q3 23 | Q4 23 | Q1 24 | Q2 24 | Q3 24 | Q4 24 | Q1 25 | Q2 25 | Q3 25 | Q4 25 | Q1 26 | Q2 26 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | 100.0% | |
| 80.4% | 86.4% | 92.8% | 86.1% | 88.9% | 90.4% | 89.1% | 89.2% | 93.3% | 97.1% | 97.2% | 96.4% | |
| 24.4% | 17.0% | 45.3% | 20.5% | 25.3% | 29.9% | 44.4% | 46.4% | 29.4% | 33.3% | 26.7% | 21.7% | |
| 78.5% | 84.8% | 91.5% | 84.5% | 87.4% | 87.6% | 86.6% | 86.5% | 91.8% | 96.1% | 95.9% | 94.9% | |
| 14.8% | 17.7% | 11.3% | 13.2% | 18.1% | 21.8% | 22.8% | 43.6% | 29.0% | 32.1% | 32.7% | 36.2% | |
| 9.8% | 12.2% | 7.7% | 9.3% | 13.8% | 17.0% | 17.4% | 21.3% | 14.6% | 6.8% | 6.4% | 7.1% | |
| 0.4% | 0.4% | 0.3% | 0.3% | 0.4% | 0.5% | 0.6% | 0.6% | 0.4% | 0.2% | 0.2% | 0.2% | |
| 2.8% | 3.4% | 3.3% | 2.1% | 3.9% | 3.7% | 5.0% | 6.0% | 3.8% | 1.0% | 1.5% | 0.9% | |
| – | – | – | – | – | – | – | 16.0% | 10.4% | 23.8% | 24.7% | 26.8% | |
| 85.2% | 82.3% | 88.7% | 86.8% | 81.9% | 78.2% | 77.2% | 56.4% | 71.0% | 67.9% | 67.3% | 63.8% | |
| -154.5% | -192.6% | -139.0% | -167.7% | -206.1% | -262.1% | -328.2% | -365.7% | -255.0% | -126.8% | -142.4% | -165.6% | |
| 24.2% | 27.7% | 19.9% | 23.1% | 28.7% | 33.7% | 40.1% | 41.5% | 32.8% | 17.2% | 18.9% | 20.5% |
Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)
Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.